Related Experiment Video
Updated: Sep 25, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Vasospasm-induced ST-segment elevation myocardial infarction in a premenopausal woman with endothelial dysfunction
Bonpei Takase1, Yukie Kobayashi2, Natsuko Sasaki2
1Department of Intensive Care Medicine, National Defense Medical College, Tokorozawa city, Saitama, Japan.
Insights
Coronary artery vasospasm causes ST-elevation myocardial infarction (STEMI) due to endothelial dysfunction. Endothelial function tests like FMD and EndPAT may predict outcomes in women with VSA-induced STEMI.
Area of Science:
- Cardiology
- Vascular Biology
- Diagnostic Medicine
Background:
- ST-segment elevation myocardial infarction (STEMI) can arise from coronary artery vasospasm (VSA), linked to endothelial dysfunction.
- The diagnostic utility of endothelial function tests in VSA-induced STEMI remains unclear.
Observation:
- A case study of a 43-year-old woman with atypical chest pain and no traditional risk factors was presented.
- STEMI attributed to VSA was diagnosed in this patient.
- Flow-mediated vasodilatation (FMD) measured 3.8%, and the reactive hyperaemia index (EndPAT) was 1.23.
Findings:
- Endothelial dysfunction is identified as the likely cause of STEMI in this case.
- The patient's low FMD and reactive hyperaemia index suggest significant endothelial impairment.
Implications:
- Endothelial function tests, specifically FMD and EndPAT, may serve as valuable tools for prognostication.
- These tests could help predict adverse outcomes in young, premenopausal women experiencing VSA-induced STEMI.
Abstract:
ST-segment elevation myocardial infarction (STEMI) can be caused by coronary artery vasospasm (VSA) due to endothelial dysfunction. However, the clinical role of endothelial function tests in VSA-induced STEMI is not fully understood. We present the case of a 43-year-old woman with atypical chest pain and no coronary risk factors. STEMI caused by VSA was diagnosed. Flow-mediated vasodilatation (FMD) and EndPAT tests were performed; the FMD and reactive hyperaemia index were 3.8% and 1.23, respectively. Endothelial dysfunction is the putative cause of STEMI. FMD and EndPAT tests might be useful for predicting adverse outcomes in young premenopausal women with VSA.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Related Concept Videos
Vascular Spasm
Acute Coronary Syndrome I: Introduction
Venous Thrombosis I: Introduction
Angina III: Clinical Manifestations and Assessment
Angina I: Introduction
Peripheral Artery Disease I: Introduction